Chemotherapy in Treating Patients Who Have Hematologic Cancer
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of DX-8951f in treating patients who have
hematologic cancer.